Tags

Type your tag names separated by a space and hit enter

Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers.
J Gen Intern Med. 2022 08; 37(11):2786-2794.JG

Abstract

BACKGROUND

Hospitalizations related to opioid use disorder (OUD) are rising. Addiction consultation services (ACS) increasingly provide OUD treatment to hospitalized patients, but barriers to initiating and continuing medications for OUD remain. We examined facilitators and barriers to hospital-based OUD treatment initiation and continuation from the perspective of patients and healthcare workers in the context of an ACS.

METHODS

In this qualitative study, we sought input using key informant interviews and focus groups from patients who received care from an ACS during their hospitalization and from hospitalists, pharmacists, social workers, and nurses who work in the hospital setting. A multidisciplinary team coded and analyzed transcripts using a directed content analysis.

FINDINGS

We conducted 20 key informant interviews with patients, nine of whom were interviewed following hospital discharge and 12 of whom were interviewed during a rehospitalization. We completed six focus groups and eight key informant interviews with hospitalists and hospital-based medical staff (n = 62). Emergent themes related to hospital-based OUD treatment included the following: the benefit of an ACS to facilitate OUD treatment engagement; expanded use of methadone or buprenorphine to treat opioid withdrawal; the triad of hospitalization, self-efficacy, and easily accessible, patient-centered treatment motivates change in opioid use; adequate pain control and stabilization of mental health conditions among patients with OUD contributed to opioid agonist therapy (OAT) continuation; and stable housing and social support are prerequisites for OAT uptake and continuation.

CONCLUSION

Modifiable factors which facilitate hospital-based OUD treatment initiation and continuation include availability of in-hospital addiction expertise to offer easily accessible, patient-centered treatment and the use of methadone or buprenorphine to manage opioid withdrawal. Further research and public policy efforts are urgently needed to address reported barriers to hospital-based OUD treatment initiation and continuation which include unstable housing, poorly controlled chronic medical and mental illness, and lack of social support.

Authors+Show Affiliations

Division of General Internal Medicine, University of Colorado, 8th Floor, Academic Office 1, Mailstop B180, 12631 E 17th Ave, Aurora, CO, 80045, USA. susan.calcaterra@cuanschutz.edu. Division of Hospital Medicine, University of Colorado, Aurora, CO, USA. susan.calcaterra@cuanschutz.edu.Adult and Child Consortium for Health Outcomes Research and Delivery Service, Univeristy of Colorado, School of Medicine and Children's Hospital Colorado, Aurora, CO, USA.Division of Hospital Medicine, University of Colorado, Aurora, CO, USA.Clinical Science Graduate Program, University of Colorado, Aurora, CO, USA.Division of General Internal Medicine, University of Colorado, 8th Floor, Academic Office 1, Mailstop B180, 12631 E 17th Ave, Aurora, CO, 80045, USA. Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA. Colorado Permanente Medical Group, Aurora, CO, USA. Bernard J. Tyson School of Medicine, Pasadena, CA, USA.

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural

Language

eng

PubMed ID

34981359

Citation

Calcaterra, Susan L., et al. "Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers." Journal of General Internal Medicine, vol. 37, no. 11, 2022, pp. 2786-2794.
Calcaterra SL, Lockhart S, Callister C, et al. Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers. J Gen Intern Med. 2022;37(11):2786-2794.
Calcaterra, S. L., Lockhart, S., Callister, C., Hoover, K., & Binswanger, I. A. (2022). Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers. Journal of General Internal Medicine, 37(11), 2786-2794. https://doi.org/10.1007/s11606-021-07305-3
Calcaterra SL, et al. Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers. J Gen Intern Med. 2022;37(11):2786-2794. PubMed PMID: 34981359.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers. AU - Calcaterra,Susan L, AU - Lockhart,Steve, AU - Callister,Catherine, AU - Hoover,Kaitlyn, AU - Binswanger,Ingrid A, Y1 - 2022/01/03/ PY - 2021/08/07/received PY - 2021/11/23/accepted PY - 2022/1/5/pubmed PY - 2022/8/30/medline PY - 2022/1/4/entrez KW - addiction KW - buprenorphine KW - methadone KW - opioid agonist KW - opioid use disorder KW - qualitative SP - 2786 EP - 2794 JF - Journal of general internal medicine JO - J Gen Intern Med VL - 37 IS - 11 N2 - BACKGROUND: Hospitalizations related to opioid use disorder (OUD) are rising. Addiction consultation services (ACS) increasingly provide OUD treatment to hospitalized patients, but barriers to initiating and continuing medications for OUD remain. We examined facilitators and barriers to hospital-based OUD treatment initiation and continuation from the perspective of patients and healthcare workers in the context of an ACS. METHODS: In this qualitative study, we sought input using key informant interviews and focus groups from patients who received care from an ACS during their hospitalization and from hospitalists, pharmacists, social workers, and nurses who work in the hospital setting. A multidisciplinary team coded and analyzed transcripts using a directed content analysis. FINDINGS: We conducted 20 key informant interviews with patients, nine of whom were interviewed following hospital discharge and 12 of whom were interviewed during a rehospitalization. We completed six focus groups and eight key informant interviews with hospitalists and hospital-based medical staff (n = 62). Emergent themes related to hospital-based OUD treatment included the following: the benefit of an ACS to facilitate OUD treatment engagement; expanded use of methadone or buprenorphine to treat opioid withdrawal; the triad of hospitalization, self-efficacy, and easily accessible, patient-centered treatment motivates change in opioid use; adequate pain control and stabilization of mental health conditions among patients with OUD contributed to opioid agonist therapy (OAT) continuation; and stable housing and social support are prerequisites for OAT uptake and continuation. CONCLUSION: Modifiable factors which facilitate hospital-based OUD treatment initiation and continuation include availability of in-hospital addiction expertise to offer easily accessible, patient-centered treatment and the use of methadone or buprenorphine to manage opioid withdrawal. Further research and public policy efforts are urgently needed to address reported barriers to hospital-based OUD treatment initiation and continuation which include unstable housing, poorly controlled chronic medical and mental illness, and lack of social support. SN - 1525-1497 UR - https://www.unboundmedicine.com/medline/citation/34981359/Opioid_Use_Disorder_Treatment_Initiation_and_Continuation:_a_Qualitative_Study_of_Patients_Who_Received_Addiction_Consultation_and_Hospital_Based_Providers_ DB - PRIME DP - Unbound Medicine ER -